| 000 | 01221 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513104713.0 | ||
| 264 | 0 | _c19970114 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0340-6199 | ||
| 024 | 7 |
_a10.1007/BF01953955 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNash, M C | |
| 245 | 0 | 0 |
_aNo evidence for use of pentoxifylline in acute Kawasaki disease. _h[electronic resource] |
| 260 |
_bEuropean journal of pediatrics _cMar 1996 |
||
| 300 |
_a258 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comment; Comparative Study; Letter; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMucocutaneous Lymph Node Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 700 | 1 | _aWade, A M | |
| 773 | 0 |
_tEuropean journal of pediatrics _gvol. 155 _gno. 3 _gp. 258 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01953955 _zAvailable from publisher's website |
| 999 |
_c8922172 _d8922172 |
||